Millicom International Cellular S.A. Common Stock vs Tilray Brands Inc — how do they compare? Millicom International Cellular S.A. Common Stock trades at $80.27 (market cap $13.34B), while Tilray Brands Inc trades at $3.11 (market cap $481.79M). The key difference: Millicom International Cellular S.A. Common Stock is far larger — about 27.7× Tilray Brands Inc's market cap, and Millicom International Cellular S.A. Common Stock pays a 3.77% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Millicom International Cellular S.A. Common Stock for 0 Days and Tilray Brands Inc for 31 Days on average.
| TIGO | TLRY | |
|---|---|---|
Market Cap | $13.34B | $481.79M |
Volume | 1,586,684 | 4,056,443 |
Sector | Media | Health |
52-Week High | $104.31 | $16.80 |
52-Week Low | $45.81 | $3.14 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $24.38B | $635.71M |
Dividend Yield | 3.77% | — |
Signals from Pluang's Aura AI — not financial advice
TIGO trades at $79.54, down 0.92% on the day, with a neutral technical signal and key support at $79. The company reported strong 2025 results with $5.82B revenue and $1.32B net income, but 2026 earnings have missed expectations in two of the last three quarters. Recent news highlights its addition to Zacks' Strong Buy list and a consistent $0.75 quarterly dividend.
The stock offers a 12.9% upside to the consensus price target of $89.78, supported by solid profitability and cash flow, but faces risks from earnings volatility and high debt. Analyst sentiment is mixed with a Hold consensus, suggesting cautious optimism amid integration challenges from recent acquisitions.
Tilray Brands (TLRY) trades at $3.27, down 2.68% on the day and near 52-week lows, with bearish technical signals dominating. The company reported $821 million in revenue for 2025 but posted a massive $2.19 billion net loss due to impairment charges. Recent earnings misses and negative cash flow from operations highlight ongoing profitability challenges despite analyst consensus pointing to significant upside potential.
TLRY presents a high-risk opportunity with substantial analyst price target divergence. While valuation metrics appear attractive (P/S 0.4x, P/B 0.3x), persistent losses and cash burn require careful monitoring. The stock's fate hinges on cannabis reform progress and the company's ability to achieve sustainable profitability amid competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Millicom International Cellular S.A. operates telecommunications and digital services under the Tigo brand across Latin America, providing mobile, fiber broadband, and pay-TV services. The company also offers mobile financial services through its Tigo Money business.
Read more on TIGO →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →